Asthma Clinical Trials in Chengdu, Sichuan
5 recruitingChengdu, Sichuan, China
Showing 1–5 of 5 trials
Recruiting
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
Asthma
AstraZeneca355 enrolled21 locationsNCT06419413
Recruiting
Phase 2
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Asthma
Pfizer252 enrolled125 locationsNCT06977581
Recruiting
Phase 2
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Eosinophilic Asthma Patients
Guangdong Hengrui Pharmaceutical Co., Ltd200 enrolled1 locationNCT06441812
Recruiting
Phase 3
A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma
Asthma With Eosinophilic Phenotype
Guangdong Hengrui Pharmaceutical Co., Ltd400 enrolled1 locationNCT06653322
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis
China-Japan Friendship Hospital2,000 enrolled9 locationsNCT06798077